Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) commenced an underwritten public offering of $50,000,000 of shares of its common stock. Rocket also ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE